bpc-157 randomized controlled trials rcts (RCTs) Application of peptide therapy for

On the basis of the results available up to date, the Global Initiative for Chronic Obstructive Lung Disease [119] recognizes that mucolytic and antioxidant drugs, such as NAC, can be used as an adjunct therapy to reduce the risk of acute exacerbation of COPD, but in a limited way due to the lack of robust randomized controlled clinical trials (level of evidence B)

Unless specifically directed by a prescribing clinician, stick with bacteriostatic water for consistency and simplicity

Mar 2010;19(1):31-36

And so I'm always a little skeptical when it comes to that

Angiogenesis and Vascular Signalling Models: Investigating peptide-mediated signalling related to vascular and angiogenic pathways